Synopsis
Synopsis
0
JDMF
0
VMF
0
Listed Dossiers
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
2. Cp 88059
3. Cp 88059-01
4. Cp-88,059
5. Cp-88,059-01
6. Cp-88,059-1
7. Geodon
8. Ziprasidone
9. Ziprasidone Hydrochloride, Monohydrate
10. Ziprazidone
1. 122883-93-6
2. Ziprasidone Hcl
3. Geodon
4. Zeldox
5. 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one Hydrochloride
6. Ziprasidone (hydrochloride)
7. 5-[2-[4-(1,2-benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one Hydrochloride
8. Ziprasidone Hydrochloride [usan]
9. Jal53626gg
10. 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one Hydrochloride
11. 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one Hydrochloride
12. Cp 88059 (hydrochloride Monohydrate)
13. 122883-93-6 (hcl)
14. 2h-indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, Monohydrochloride
15. 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1h-indol-2-one Hydrochloride
16. Cp 88059
17. Ziprasidone Hydrochloride Hydrate
18. C21h21cln4os.hcl
19. Unii-jal53626gg
20. Ziprasidone, Hcl
21. 2h-indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, Hydrochloride (1:1)
22. 2h-indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, Hydrochloride (1:1)
23. Cp-88059 Hydrochloride
24. Chembl1712
25. Mls006010221
26. Schembl122876
27. Dtxsid00153762
28. Hy-14542a
29. S1444
30. Akos015848366
31. Ac-7053
32. Ccg-220561
33. Cs-1887
34. Ks-1219
35. 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrochloride
36. Ac-26998
37. Smr002204092
38. Ziprasidone Hydrochloride Anhydrous
39. Sw199027-2
40. Z0032
41. Ziprasidone Hydrochloride Anhydrous [mi]
42. 939z277
43. A890906
44. Sr-01000759387
45. Sr-01000759387-2
46. Ziprasidone Hydrochloride Anhydrous [who-dd]
47. Q27281411
48. 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one Hcl
49. 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone Monohydrochloride
50. 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)-ethyl)-6-chloroindolin-2-one Hydrochloride
51. 5-[2-[4-(1,2-benzisothiazol-3-yl)-1 -piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol- 2-one Hydrochloride
52. 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1, 3-dihydro-2h-indol-2-one Hydrochloride
53. Ziprasidone Hydrochloride Solution, 1.0 Mg/ml In Methanol, Certified Reference Material, Ampule Of 1 Ml
Molecular Weight | 449.4 g/mol |
---|---|
Molecular Formula | C21H22Cl2N4OS |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 448.0891379 g/mol |
Monoisotopic Mass | 448.0891379 g/mol |
Topological Polar Surface Area | 76.7 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 573 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Ziprasidone hydrochloride |
Drug Label | GEODON is available as capsules (ziprasidone hydrochloride) for oral administration and as an injection (ziprasidone mesylate) for intramuscular use only. Ziprasidone is a psychotropic agent that is chemically unrelated to phenothiazine or butyrophen... |
Active Ingredient | Ziprasidone hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | eq 20mg base; eq 40mg base; eq 80mg base; eq 60mg base |
Market Status | Prescription |
Company | Mylan Pharms; Wockhardt; Apotex; Lupin Pharms; Sandoz; Dr Reddys Labs |
2 of 2 | |
---|---|
Drug Name | Ziprasidone hydrochloride |
Drug Label | GEODON is available as capsules (ziprasidone hydrochloride) for oral administration and as an injection (ziprasidone mesylate) for intramuscular use only. Ziprasidone is a psychotropic agent that is chemically unrelated to phenothiazine or butyrophen... |
Active Ingredient | Ziprasidone hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | eq 20mg base; eq 40mg base; eq 80mg base; eq 60mg base |
Market Status | Prescription |
Company | Mylan Pharms; Wockhardt; Apotex; Lupin Pharms; Sandoz; Dr Reddys Labs |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ziprasidone Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ziprasidone Hydrochloride, including repackagers and relabelers. The FDA regulates Ziprasidone Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ziprasidone Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ziprasidone Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ziprasidone Hydrochloride supplier is an individual or a company that provides Ziprasidone Hydrochloride active pharmaceutical ingredient (API) or Ziprasidone Hydrochloride finished formulations upon request. The Ziprasidone Hydrochloride suppliers may include Ziprasidone Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Ziprasidone Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ziprasidone Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Ziprasidone Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Ziprasidone Hydrochloride DMFs exist exist since differing nations have different regulations, such as Ziprasidone Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ziprasidone Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Ziprasidone Hydrochloride USDMF includes data on Ziprasidone Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ziprasidone Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ziprasidone Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ziprasidone Hydrochloride Drug Master File in Korea (Ziprasidone Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ziprasidone Hydrochloride. The MFDS reviews the Ziprasidone Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Ziprasidone Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ziprasidone Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ziprasidone Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ziprasidone Hydrochloride suppliers with KDMF on PharmaCompass.
A Ziprasidone Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Ziprasidone Hydrochloride Certificate of Suitability (COS). The purpose of a Ziprasidone Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ziprasidone Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ziprasidone Hydrochloride to their clients by showing that a Ziprasidone Hydrochloride CEP has been issued for it. The manufacturer submits a Ziprasidone Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ziprasidone Hydrochloride CEP holder for the record. Additionally, the data presented in the Ziprasidone Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ziprasidone Hydrochloride DMF.
A Ziprasidone Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ziprasidone Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ziprasidone Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Ziprasidone Hydrochloride written confirmation (Ziprasidone Hydrochloride WC) is an official document issued by a regulatory agency to a Ziprasidone Hydrochloride manufacturer, verifying that the manufacturing facility of a Ziprasidone Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ziprasidone Hydrochloride APIs or Ziprasidone Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Ziprasidone Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Ziprasidone Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ziprasidone Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ziprasidone Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ziprasidone Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ziprasidone Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ziprasidone Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ziprasidone Hydrochloride suppliers with NDC on PharmaCompass.
Ziprasidone Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ziprasidone Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ziprasidone Hydrochloride GMP manufacturer or Ziprasidone Hydrochloride GMP API supplier for your needs.
A Ziprasidone Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Ziprasidone Hydrochloride's compliance with Ziprasidone Hydrochloride specifications and serves as a tool for batch-level quality control.
Ziprasidone Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Ziprasidone Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ziprasidone Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Ziprasidone Hydrochloride EP), Ziprasidone Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ziprasidone Hydrochloride USP).
LOOKING FOR A SUPPLIER?